HIV Citation List: March 16 - March 29, 2012

Pubmed citations

1. Leukotrienes Inhibit Early Stages of HIV-1 Infection in Monocyte-derived Microglia-like cells. Bertin, J., C. Barat, D. Belanger, and M.J. Tremblay, Journal of Neuroinflammation, 2012. 9(1): p. 55; PMID[22424294].
[PubMed]. HIV_0316-032912.

2. Phenolic Compounds from Nicotiana tabacum and Their Biological Activities. Chen, Y.K., X.S. Li, G.Y. Yang, Z.Y. Chen, Q.F. Hu, and M.M. Miao, Journal of Asian Natural Products Research, 2012. [Epub ahead of print]; PMID[22428563].
[PubMed]. HIV_0316-032912.

3. Soluble Factors from T Cells Inhibiting X4 Strains of HIV are a Mixture of Beta Chemokines and RNases. Cocchi, F., A.L. Devico, W. Lu, M. Popovic, O. Latinovic, M.M. Sajadi, R.R. Redfield, M.K. Lafferty, M. Galli, A. Garzino-Demo, and R.C. Gallo, Proceedings of the National Academy of Sciences of the United States of America, 2012. [Epub ahead of print]; PMID[22431590].
[PubMed]. HIV_0316-032912.

4. Characterization in an ex Vivo Ectocervical Model of UC781/Tenofovir Combination Gel Products for HIV-1 Prevention. Cost, M., C.S. Dezzutti, M.R. Clark, D.R. Friend, A. Akil, and L.C. Rohan, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22430977].
[PubMed]. HIV_0316-032912.

5. Inhibition of HIV-1 Replication with Stable RNAi-mediated Knockdown of Autophagy Factors. Eekels, J.J., S. Sagnier, D. Geerts, R.E. Jeeninga, M. Biard-Piechaczyk, and B. Berkhout, Virology Journal, 2012. 9(1): p. 69; PMID[22424437].
[PubMed]. HIV_0316-032912.

6. CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection and a Resistant Variant. Kang, Y., Z. Wu, T.C. Lau, X. Lu, L. Liu, A.K. Cheung, Z. Tan, J. Ng, J. Liang, H. Wang, S.K. Li, B. Zheng, B. Li, L. Chen, and Z. Chen, The Journal of Biological Chemistry, 2012. [Epub ahead of print]; PMID[22447925].
[PubMed]. HIV_0316-032912.

7. A Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors. Kessl, J.J., N. Jena, Y. Koh, H. Taskent-Sezgin, A. Slaughter, L. Feng, S. de Silva, L. Wu, S.F. Le Grice, A. Engelman, J.R. Fuchs, and M. Kvaratskhelia, The Journal of Biological Chemistry, 2012. [Epub ahead of print]; PMID[22437836].
[PubMed]. HIV_0316-032912.

8. First-In-Class Small Molecule Inhibitors of the Single-strand DNA Cytosine Deaminase APOBEC3G. Li, M., S.M. Shandilya, M.A. Carpenter, A. Rathore, W.L. Brown, A.L. Perkins, D.A. Harki, J. Solberg, D.J. Hook, K.K. Pandey, M.A. Parniak, J.R. Johnson, N.J. Krogan, M. Somasundaran, A. Ali, C.A. Schiffer, and R.S. Harris, ACS Chemical Biology, 2012. 7(3): p. 506-517; PMID[22181350].
[PubMed]. HIV_0316-032912.

9. Capsid Assembly as a Point of Intervention for Novel Anti-viral Therapeutics. Lingappa, V.R., C.R. Hurt, and E. Garvey, Current Pharmaceutical Biotechnology, 2012. [Epub ahead of print]; PMID[22429134].
[PubMed]. HIV_0316-032912.

10. Sublimable C5A Delivery Provides Sustained and Prolonged anti-HIV Microbicidal Activities. Maskiewicz, R., M. Bobardt, U. Chatterji, S. Gunaseelan, C.S. Dezzutti, F. Penin, and P.A. Gallay, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22430971].
[PubMed]. HIV_0316-032912.

11. Recent Advances in the Research of 2,3-Diaryl-1,3-thiazolidin-4-one Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Tian, Y., P. Zhan, D. Rai, J. Zhang, E. De Clercq, and X. Liu, Current Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22429098].
[PubMed]. HIV_0316-032912.

12. Library-based Discovery and Characterization of Daphnane Diterpenes as Potent and Selective HIV Inhibitors in Daphne gnidium. Vidal, V., O. Potterat, S. Louvel, F. Hamy, M. Mojarrab, J.J. Sanglier, T. Klimkait, and M. Hamburger, Journal of Natural Products, 2012. 75(3): p. 414-419; PMID[22148316]. [PubMed]. HIV_0316-032912.

ISI Web of Knowledge citations

13. Combination of Antiretroviral Drugs as Microbicides. Balzarini, J. and D. Schols, Current HIV Research, 2012. 10(1): p. 53-60; ISI[000300409000008].
[WOS]. HIV_0302-031512.

14. Denaturation of HIV-1 Protease (PR) Monomer by Acetic Acid: Mechanistic and Trajectory Insights from Molecular Dynamics Simulations and NMR. Borkar, A., M. Rout, and R. Hosur, Journal of Biomolecular Structure & Dynamics, 2012. 29(5): p. 893-903; ISI[000300074600004].
[WOS]. HIV_0302-031512.

15. Thymidine- and AZT-linked 5-(1,3-Dioxoalkyl)tetrazoles and 4-(1,3-Dioxoalkyl)-1,2,3-triazoles. Bosch, L., O. Delelis, F. Subra, E. Deprez, M. Witvrow, and J. Vilarrasa, Tetrahedron Letters, 2012. 53(5): p. 514-518; ISI[000300029000011].
[WOS]. HIV_0302-031512.

16. Synthesis of 1,5-Benzothiazepine Derivatives Bearing 2-Phenoxy-quinoline Moiety via 1,3-Diplolar Cycloaddition Reaction. Dong, Z.Q., F.M. Liu, F. Xu, and Z.L. Yuan, Molecular Diversity, 2011. 15(4): p. 963-970; ISI[000300364700014].
[WOS]. HIV_0302-031512.

17. Phenols with anti-HIV Activity from Daphne acutiloba. Huang, S.Z., X. Zhang, X. Li, H. Jiang, Q. Ma, P. Wang, Y. Liu, J. Hu, Y. Zheng, J. Zhou, and Y. Zhao, Planta Medica, 2012. 78(2): p. 182-185; ISI[000299909300014].
[WOS]. HIV_0302-031512.

18. Evaluation of Competing Process Concepts for the Production of Pure Enantiomers. Kaspereit, M., S. Swernath, and A. Kienle, Organic Process Research & Development, 2012. 16(2): p. 353-363; ISI[000300339700024].
[WOS]. HIV_0302-031512.

19. A QSAR Study on a Series of N-Methyl pyrimidones Acting as HIV Integrase Inhibitors. Kaushik, S., S. Gupta, P. Sharma, and Z. Anwer, Indian Journal of Biochemistry & Biophysics, 2011. 48(6): p. 427-434; ISI[000299859600009].
[WOS]. HIV_0302-031512.

20. Recent Advances in the Development of Small-molecule Compounds Targeting HIV-1 gp41 as Membrane Fusion Inhibitors. Kawashita, N., Y.S. Tian, U.C. de Silva, K. Okamoto, and T. Takagi, Mini-Reviews in Organic Chemistry, 2012. 9(1): p. 20-26; ISI[000300407400005].
[WOS]. HIV_0302-031512.

21. Three New Arylnaphthalene Lignans from Schisandra propinqua var. Sinensis. Li, X.N., C. Lei, L.M. Yang, H.M. Li, S.X. Huang, X. Du, J.X. Pu, W.L. Xiao, Y.T. Zheng, and H.D. Sun, Fitoterapia, 2012. 83(1): p. 249-252; ISI[000300201300037].
[WOS]. HIV_0302-031512.

22. Involvement of K(v)1.3 and p38 MAPK Signaling in HIV-1 Glycoprotein 120-induced Microglia Neurotoxicity. Liu, J., C. Xu, L. Chen, P. Xu, and H. Xiong, Cell Death & Disease, 2012. 3; ISI[000300322700008].
[WOS]. HIV_0302-031512.

23. Quinoxalinone Inhibitors of the Lectin DC-SIGN. Mangold, S.L., L. Prost, and L. Kiessling, Chemical Science, 2012. 3(3): p. 772-777; ISI[000299949500016].
[WOS]. HIV_0302-031512.

24. HIV-1 Subtype and Virological Response to Antiretroviral Therapy: Acquired Drug Resistance. Soares, E.A., A.F. Santos, and M.A. Soares, Clinical Infectious Diseases, 2012. 54(5): p. 738-738; ISI[000300228300025].
[WOS]. HIV_0302-031512.

25. Dihydro-alkoxyl-benzyl-oxopyrimidine Derivatives (DABOs) As Non-Nucleoside Reverse Transcriptase Inhibitors: An Update Review (2001-2011). Yang, S.Q., F.E. Chen, and E. De Clercq, Current Medicinal Chemistry, 2012. 19(2): p. 152-162; ISI[000300284100001].
[WOS]. HIV_0302-031512.